Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Structure Therapeutics
Biotech
Structure touts 16% weight loss 'highest efficacy' for oral GLP1
Structure has touted the 16% weight loss seen by aleniglipron as the best results yet for an oral GLP-1 drug.
James Waldron
Mar 16, 2026 10:02am
Roche commits $100M to keep its GLP-1 Structure sound
Jan 6, 2026 10:21am
Wave, Structure stocks double on obesity data readouts
Dec 8, 2025 10:50am
2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders
Sep 20, 2024 8:30am
Structure patches up shares after GLP-1 linked to 6% weight loss
Jun 3, 2024 10:17am
Xaira, Anthos, CureVac & more—Chutes & Ladders
Apr 26, 2024 8:30am
